| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4323489 | Brain Research | 2016 | 6 Pages |
Abstract
Increased [11C]DTBZ binding may indicate vesicular monoamine transporter type 2 (VMAT2) function is altered. The lack of extrapyramidal symptoms in animals could be attributed to low dosing regimen or high metabolic rate.
Keywords
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Andres Asser, Sulev Kõks, Anniina Snellman, Merja Haaparanta-Solin, Eveliina Arponen, Tove Grönroos, Jaak Nairismägi, Jonas Bergquist, Ursel Soomets, Piret Piip, Mall Eltermaa, Martin Sauk, Hanna Lindmäe, Juha O. Rinne, Pille Taba,